We work from the ground up, studying the molecular and cellular basis of brain tumours and neurodegenerative disease. Through increased understanding of these diseases we are able to develop new and effective treatments.
Our extensive expertise in neuropathology (diseases of the nervous system) allows us to analyse the molecular and cellular basis of neurological diseases, including brain tumours and neurodegenerative conditions.
In doing so, we can identify new ways of diagnosing these disorders early on, when the disease first manifests. This means patients can benefit from the most effective interventions available as early as possible. By increasing our knowledge of the underlying basis of these diseases, we can help progress the development of new and more effective treatments.
To this end, we are working to develop novel blood tests that aim to detect major diseases early on, including brain tumours and multiple sclerosis. We are also investigating brain tumour tissue to learn more about its complex genetic makeup, and how brain tumours manipulate their surroundings in order to grow.
Our neuropathology research program is also part of the Royal Prince Alfred Department of Neuropathology, the only neuropathology department in New South Wales to provide specialist diagnostic expertise including: